Doménech J, Carulla M, Traserra J
Cátedra de ORL, Facultad de Medicina, Universidad de Barcelona.
Acta Otorrinolaringol Esp. 1990 Jan-Feb;41(1):7-9.
The prognostic value of tinnitus about the occurrence of hypoacusia in a patient undergoing an ototoxic treatment is not know. Ninety-five patients treated with cisplatinum, a cocleotoxic drug, have been studied to evaluate the percentage of patients with tinnitus, to assess the characteristics of these tinnitus and to know if there is a relationship between its occurrence and the degree of hearing loss that appears after treatment. Thirty-six patients (37.9%) had tinnitus, and there was not a statistically significant relationship between this symptom and the hearing loss. Therefore, tinnitus cannot be used as a prognostic factor for hypoacusia in patients undergoing treatment with cisplatinum.
耳鸣对于接受耳毒性治疗患者发生听力减退的预后价值尚不清楚。我们对95例接受顺铂（一种耳毒性药物）治疗的患者进行了研究，以评估耳鸣患者的比例，评估这些耳鸣的特征，并了解耳鸣的发生与治疗后出现的听力损失程度之间是否存在关联。36例患者（37.9%）有耳鸣，且该症状与听力损失之间无统计学显著关联。因此，耳鸣不能用作接受顺铂治疗患者听力减退的预后因素。
